PSAT1 Inhibitors

PSAT1 inhibitors encompass a variety of chemicals that indirectly modulate the function and activity of PSAT1, a key enzyme in the serine biosynthesis pathway. These inhibitors primarily function by targeting the amino acid metabolism and serine biosynthesis, which are crucial for PSAT1's role in cellular metabolism. Compounds such as Aminooxyacetic Acid and Hydroxylamine interfere with the enzyme's cofactor, pyridoxal phosphate, potentially inhibiting PSAT1's catalytic activity. Gabaculine, with its structural similarity to serine, and Cycloserine, an antibiotic affecting alanine metabolism, can indirectly influence serine biosynthesis and therefore PSAT1 activity.

Other inhibitors, such as Methotrexate, which affects one-carbon metabolism, and Azaserine and DON, both glutamine metabolism inhibitors, represent another approach to modulating PSAT1 by influencing related metabolic pathways. Glyphosate, known for inhibiting the shikimate pathway, and Benserazide, which inhibits DOPA decarboxylase, may also impact amino acid metabolism, indirectly influencing PSAT1. L-Serine, as a product of the reaction catalyzed by PSAT1, could provide feedback inhibition, while Ethanolamine and L-Phenylalanine, through their involvement in phospholipid and amino acid metabolism, respectively, might interact with pathways involving PSAT1.